Ftse Mib
34.478,84
0,05%
DAX
18.691,32
0,05%
S&P 500
5.267,84
-0,74%
NASDAQ
16.736,03
-0,39%
Bitcoin
67.333,64
-2,56%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Stereotaxis Inc (STXS) Stereotaxis Inc (STXS) Notizie

Stereotaxis Inc

STXS
2,02
-0,07 (-3,35%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:00:10
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/5/202414:42GLOBEFirst Heart Rhythm Patients in Southern Italy Treated with..
16/5/202423:00EDGAR2Form 8-K - Current report
15/5/202416:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202414:52GLOBEStereotaxis Invited by Africa Heart Rhythm Association to..
13/5/202422:10EDGAR2Form 8-K - Current report
13/5/202422:03GLOBEStereotaxis Reports 2024 First Quarter Financial Results
13/5/202422:02GLOBEStereotaxis Announces Definitive Agreement to Acquire Access..
22/4/202413:51GLOBEStereotaxis to Report First Quarter 2024 Financial Results..
08/3/202421:21EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
04/3/202422:06EDGAR2Form 8-K - Current report
04/3/202422:06GLOBEStereotaxis Announces Regulatory Submissions of the MAGiC..
04/3/202422:05GLOBEStereotaxis Reports 2023 Full Year Financial Results
22/2/202422:15GLOBEIntermountain Health Extends Leadership in Heart Care with..
20/2/202415:05GLOBEStereotaxis to Report Fourth Quarter and Full Year 2023..
14/2/202422:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202414:34GLOBEStereotaxis Announces First Patients Successfully Treated..
02/1/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202314:42GLOBEBaptist Health Lexington Enhances 20-Year Leadership in..
20/11/202314:54GLOBEStereotaxis to Participate in Piper Sandler 35th Annual..
13/11/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:05EDGAR2Form 8-K - Current report
09/11/202315:00GLOBEStereotaxis Reports 2023 Third Quarter Financial Results
31/10/202313:57GLOBEAbbott and Stereotaxis Technologies Used in First Integrated..
17/10/202315:05GLOBEStereotaxis to Report Third Quarter 2023 Financial Results..
04/10/202314:49GLOBEStereotaxis Robotic Technology to be Featured during 7th..
06/9/202314:56GLOBEHeart Centre Rigshospitalet Enhances Leadership in Patient..
30/8/202314:49GLOBEOverland Park Regional Medical Center Becomes First U.S...
16/8/202314:40GLOBELive Long-Distance TeleRobotic Procedures to Highlight..
11/8/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202315:05EDGAR2Form 8-K - Current report
10/8/202315:00GLOBEStereotaxis Reports 2023 Second Quarter Financial Results
18/7/202315:18GLOBEStereotaxis and Abbott Combine Technologies in First..
17/7/202312:00GLOBEStereotaxis to Report Second Quarter 2023 Financial Results..
03/7/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/6/202322:10GLOBEStereotaxis to Initiate First-in-Human Trial to Support CE..
25/5/202314:56GLOBEStereotaxis to Participate in 20th Annual Craig-Hallum..
Apertura: 2,09 Min: 2,00 Max: 2,09
Chiusura: 2,09

La tua Cronologia

AMEX
STXS
Stereotaxis
NASDAQ
ALIM
Alimera Sciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network